{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:05:48Z","timestamp":1787241948234,"version":"build-2736575974"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T00:00:00Z","timestamp":1646265600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T00:00:00Z","timestamp":1646265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["Postdoctoral Fellowships Program"],"award-info":[{"award-number":["Postdoctoral Fellowships Program"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","award":["Research grant for the Infection Prevention and Control (IPC) Pillar."],"award-info":[{"award-number":["Research grant for the Infection Prevention and Control (IPC) Pillar."]}],"id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Determining the viral load and infectivity of SARS-CoV-2 in macroscopic respiratory droplets, bioaerosols, and other bodily fluids and secretions is important for identifying transmission modes, assessing risks and informing public health guidelines. Here we show that viral load of SARS-CoV-2 Ribonucleic Acid (RNA) in participants\u2019 naso-pharyngeal (NP) swabs positively correlated with RNA viral load they emitted in both droplets &gt;10\n                    <jats:inline-formula>\n                      <jats:alternatives>\n                        <jats:tex-math>$$\\upmu \\hbox {m}$$<\/jats:tex-math>\n                        <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                          <mml:mrow>\n                            <mml:mi>\u03bc<\/mml:mi>\n                            <mml:mtext>m<\/mml:mtext>\n                          <\/mml:mrow>\n                        <\/mml:math>\n                      <\/jats:alternatives>\n                    <\/jats:inline-formula>\n                    and bioaerosols &lt;10\n                    <jats:inline-formula>\n                      <jats:alternatives>\n                        <jats:tex-math>$$\\upmu \\hbox {m}$$<\/jats:tex-math>\n                        <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                          <mml:mrow>\n                            <mml:mi>\u03bc<\/mml:mi>\n                            <mml:mtext>m<\/mml:mtext>\n                          <\/mml:mrow>\n                        <\/mml:math>\n                      <\/jats:alternatives>\n                    <\/jats:inline-formula>\n                    directly captured during the combined expiratory activities of breathing, speaking and coughing using a standardized protocol, although the NP swabs had\n                    <jats:inline-formula>\n                      <jats:alternatives>\n                        <jats:tex-math>$$\\approx$$<\/jats:tex-math>\n                        <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                          <mml:mo>\u2248<\/mml:mo>\n                        <\/mml:math>\n                      <\/jats:alternatives>\n                    <\/jats:inline-formula>\n                    10\n                    <jats:inline-formula>\n                      <jats:alternatives>\n                        <jats:tex-math>$$^3\\times$$<\/jats:tex-math>\n                        <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                          <mml:mrow>\n                            <mml:msup>\n                              <mml:mrow\/>\n                              <mml:mn>3<\/mml:mn>\n                            <\/mml:msup>\n                            <mml:mo>\u00d7<\/mml:mo>\n                          <\/mml:mrow>\n                        <\/mml:math>\n                      <\/jats:alternatives>\n                    <\/jats:inline-formula>\n                    more RNA on average. By identifying highly-infectious individuals (maximum of 18,000 PFU\/mL in NP), we retrieved higher numbers of SARS-CoV-2 RNA gene copies in bioaerosol samples (maximum of 4.8\n                    <jats:inline-formula>\n                      <jats:alternatives>\n                        <jats:tex-math>$${\\times }10^{5}$$<\/jats:tex-math>\n                        <mml:math xmlns:mml=\"http:\/\/www.w3.org\/1998\/Math\/MathML\">\n                          <mml:mrow>\n                            <mml:mo>\u00d7<\/mml:mo>\n                            <mml:msup>\n                              <mml:mn>10<\/mml:mn>\n                              <mml:mn>5<\/mml:mn>\n                            <\/mml:msup>\n                          <\/mml:mrow>\n                        <\/mml:math>\n                      <\/jats:alternatives>\n                    <\/jats:inline-formula>\n                    gene copies\/mL and minimum cycle threshold of 26.2) relative to other studies. However, all attempts to identify infectious virus in size-segregated droplets and bioaerosols were negative by plaque assay (0 of 58). This outcome is partly attributed to the insufficient amount of viral material in each sample (as indicated by SARS-CoV-2 gene copies) or may indicate no infectious virus was present in such samples, although other possible factors are identified.\n                  <\/jats:p>","DOI":"10.1038\/s41598-022-07301-5","type":"journal-article","created":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T06:05:35Z","timestamp":1646287535000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Viral load of SARS-CoV-2 in droplets and bioaerosols directly captured during breathing, speaking and coughing"],"prefix":"10.1038","volume":"12","author":[{"given":"Tyler J.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert T.","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashlesha P.","family":"Sonpar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chan James","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberley A.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie W.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Conly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason S.","family":"Olfert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,3]]},"reference":[{"key":"7301_CR1","unstructured":"World Health Organization. Infection prevention and control of epidemic- and pandemic-prone acute respiratory infections in health care. https:\/\/www.who.int\/publications\/i\/item\/infection-prevention-and-control-of-epidemic-and-pandemic-prone-acute-respiratory-infections-in-health-care (2014)."},{"key":"7301_CR2","unstructured":"World Health Organization. Transmission of SARS-CoV-2: Implications for infection prevention precautions: Scientific brief, 9 July 2020. https:\/\/www.who.int\/publications\/i\/item\/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendations (2020). (accessed June 2021)."},{"key":"7301_CR3","unstructured":"Centers for Disease Control and Prevention (CDC). National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases. Scientific Brief: SARS-CoV-2 Transmission. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/science\/science-briefs\/sars-cov-2-transmission.html (2021). (accessed June 2021)."},{"key":"7301_CR4","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1038\/s41598-019-38808-z","volume":"9","author":"S Asadi","year":"2019","unstructured":"Asadi, S. et al. Aerosol emission and superemission during human speech increase with voice loudness. Sci. Rep. 9, 2348. https:\/\/doi.org\/10.1038\/s41598-019-38808-z (2019).","journal-title":"Sci. Rep."},{"key":"7301_CR5","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.jaerosci.2011.07.009","volume":"42","author":"GR Johnson","year":"2011","unstructured":"Johnson, G. R. et al. Modality of human expired aerosol size distributions. J. Aerosol Sci. 42, 839\u2013851. https:\/\/doi.org\/10.1016\/j.jaerosci.2011.07.009 (2011).","journal-title":"J. Aerosol Sci."},{"key":"7301_CR6","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1080\/02786826.2020.1812502","volume":"54","author":"M Alsved","year":"2020","unstructured":"Alsved, M. et al. Exhaled respiratory particles during singing and talking. Aerosol Sci. Technol. 54, 1245\u20131248. https:\/\/doi.org\/10.1080\/02786826.2020.1812502 (2020).","journal-title":"Aerosol Sci. Technol."},{"key":"7301_CR7","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1080\/02786826.2021.1883544","volume":"55","author":"FK Gregson","year":"2021","unstructured":"Gregson, F. K. et al. Comparing aerosol concentrations and particle size distributions generated by singing, speaking and breathing. Aerosol Sci. Technol. 55, 681\u2013691. https:\/\/doi.org\/10.1080\/02786826.2021.1883544 (2021).","journal-title":"Aerosol Sci. Technol."},{"key":"7301_CR8","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1017\/S0022172400019288","volume":"44","author":"JP Duguid","year":"1946","unstructured":"Duguid, J. P. The size and the duration of air-carriage of respiratory droplets and droplet-nuclei. J. Hyg. 44, 471\u2013479. https:\/\/doi.org\/10.1017\/S0022172400019288 (1946).","journal-title":"J. Hyg."},{"key":"7301_CR9","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1017\/jfm.2014.88","volume":"745","author":"L Bourouiba","year":"2014","unstructured":"Bourouiba, L., Dehandschoewercker, E. & Bush, J. W. Violent expiratory events: On coughing and sneezing. J. Fluid Mech. 745, 537\u2013563. https:\/\/doi.org\/10.1017\/jfm.2014.88 (2014).","journal-title":"J. Fluid Mech."},{"key":"7301_CR10","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/oxfordjournals.aje.a118097","volume":"20","author":"WF Wells","year":"1934","unstructured":"Wells, W. F. On air-borne infection: Study II. Droplets and droplet nuclei. Am. J. Epidemiol. 20, 611\u2013618. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a118097 (1934).","journal-title":"Am. J. Epidemiol."},{"key":"7301_CR11","unstructured":"Hinds, W.\u00a0C. Aerosol Technology: Properties, Behavior, and Measurement of Airborne Particles, 2 ed (Wiley, 1999)."},{"key":"7301_CR12","doi-asserted-by":"publisher","first-page":"e00184","DOI":"10.1128\/CMR.00184-20","volume":"34","author":"XS Zhang","year":"2020","unstructured":"Zhang, X. S. & Duchaine, C. SARS-CoV-2 and health care worker protection in low-risk settings: A review of modes of transmission and a novel airborne model involving inhalable particles. Clin. Microbiol. Rev. 34, e00184-20. https:\/\/doi.org\/10.1128\/CMR.00184-20 (2020).","journal-title":"Clin. Microbiol. Rev."},{"key":"7301_CR13","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/s41579-021-00535-6","volume":"19","author":"NH Leung","year":"2021","unstructured":"Leung, N. H. Transmissibility and transmission of respiratory viruses. Nat. Rev. Microbiol. 19, 528\u2013545. https:\/\/doi.org\/10.1038\/s41579-021-00535-6 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"7301_CR14","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1001\/jama.2020.12458","volume":"324","author":"M Klompas","year":"2020","unstructured":"Klompas, M., Baker, M. A. & Rhee, C. Airborne transmission of SARS-CoV-2: Theoretical considerations and available evidence. JAMA 324, 441\u2013442. https:\/\/doi.org\/10.1001\/jama.2020.12458 (2020).","journal-title":"JAMA"},{"key":"7301_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41586-020-2271-3","volume":"582","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals. Nature 582, 557\u2013560. https:\/\/doi.org\/10.1038\/s41586-020-2271-3 (2020).","journal-title":"Nature"},{"key":"7301_CR16","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1038\/s41467-020-16670-2","volume":"11","author":"PY Chia","year":"2020","unstructured":"Chia, P. Y. et al. Detection of air and surface contamination by SARS-CoV-2 in hospital rooms of infected patients. Nat. Commun. 11, 2800. https:\/\/doi.org\/10.1038\/s41467-020-16670-2 (2020).","journal-title":"Nat. Commun."},{"key":"7301_CR17","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1016\/S2666-5247(20)30172-5","volume":"2","author":"M Cevik","year":"2021","unstructured":"Cevik, M. et al. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: A systematic review and meta-analysis. Lancet Microbe 2, e13\u2013e22. https:\/\/doi.org\/10.1016\/S2666-5247(20)30172-5 (2021).","journal-title":"Lancet Microbe"},{"key":"7301_CR18","doi-asserted-by":"publisher","first-page":"e1870","DOI":"10.1093\/cid\/ciaa905","volume":"73","author":"J Zhou","year":"2021","unstructured":"Zhou, J. et al. Investigating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) surface and air contamination in an acute healthcare setting during the peak of the Coronavirus Disease 2019 (COVID-19) pandemic in London. Clin. Infect. Dis. 73, e1870\u2013e1877. https:\/\/doi.org\/10.1093\/cid\/ciaa905 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"7301_CR19","doi-asserted-by":"publisher","first-page":"12732","DOI":"10.1038\/s41598-020-69286-3","volume":"10","author":"JL Santarpia","year":"2020","unstructured":"Santarpia, J. L. et al. Aerosol and surface contamination of SARS-CoV-2 observed in quarantine and isolation care. Sci. Rep. 10, 12732. https:\/\/doi.org\/10.1038\/s41598-020-69286-3 (2020).","journal-title":"Sci. Rep."},{"key":"7301_CR20","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1017\/ice.2021.8","volume":"42","author":"SWX Ong","year":"2021","unstructured":"Ong, S. W. X. et al. Lack of viable SARS-CoV-2 among PCR-positive air samples from hospital rooms and community isolation facilities. Infect. Control Hosp. Epidemiol. 42, 1327\u20131332. https:\/\/doi.org\/10.1017\/ice.2021.8 (2021).","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"7301_CR21","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12860","author":"ER Robie","year":"2021","unstructured":"Robie, E. R., Abdelgadir, A., Binder, R. A. & Gray, G. C. Live SARS-CoV-2 is difficult to detect in patient aerosols. Influenza Other Respir. Viruses.https:\/\/doi.org\/10.1111\/irv.12860 (2021).","journal-title":"Influenza Other Respir. Viruses."},{"key":"7301_CR22","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1093\/infdis\/jiaa575","volume":"222","author":"RA Binder","year":"2020","unstructured":"Binder, R. A. et al. Environmental and aerosolized Severe Acute Respiratory Syndrome Coronavirus 2 among hospitalized Coronavirus Disease 2019 patients. J. Infect. Dis. 222, 1798\u20131806. https:\/\/doi.org\/10.1093\/infdis\/jiaa575 (2020).","journal-title":"J. Infect. Dis."},{"key":"7301_CR23","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1093\/nsr\/nwaa250","volume":"7","author":"J Hu","year":"2020","unstructured":"Hu, J. et al. Distribution of airborne SARS-CoV-2 and possible aerosol transmission in Wuhan hospitals, China. Natl. Sci. Rev. 7, 1865\u20131867. https:\/\/doi.org\/10.1093\/nsr\/nwaa250 (2020).","journal-title":"Natl. Sci. Rev."},{"key":"7301_CR24","doi-asserted-by":"publisher","first-page":"19589","DOI":"10.1038\/s41598-020-76442-2","volume":"10","author":"K Nissen","year":"2020","unstructured":"Nissen, K. et al. Long-distance airborne dispersal of SARS-CoV-2 in COVID-19 wards. Sci. Rep. 10, 19589. https:\/\/doi.org\/10.1038\/s41598-020-76442-2 (2020).","journal-title":"Sci. Rep."},{"key":"7301_CR25","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.ijid.2020.09.025","volume":"100","author":"JA Lednicky","year":"2020","unstructured":"Lednicky, J. A. et al. Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients. Int. J. Infect. Dis. 100, 476\u2013482. https:\/\/doi.org\/10.1016\/j.ijid.2020.09.025 (2020).","journal-title":"Int. J. Infect. Dis."},{"key":"7301_CR26","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.4209\/aaqr.2020.05.0202","volume":"20","author":"JA Lednicky","year":"2020","unstructured":"Lednicky, J. A. et al. Collection of SARS-CoV-2 virus from the air of a clinic within a university student health care center and analyses of the viral genomic sequence. Aerosol Air Qual. Res. 20, 1167\u20131171. https:\/\/doi.org\/10.4209\/aaqr.2020.05.0202 (2020).","journal-title":"Aerosol Air Qual. Res."},{"key":"7301_CR27","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.ijid.2021.04.063","volume":"108","author":"JA Lednicky","year":"2021","unstructured":"Lednicky, J. A. et al. Isolation of SARS-CoV-2 from the air in a car driven by a COVID patient with mild illness. Int. J. Infect. Dis. 108, 212\u2013216. https:\/\/doi.org\/10.1016\/j.ijid.2021.04.063 (2021).","journal-title":"Int. J. Infect. Dis."},{"key":"7301_CR28","doi-asserted-by":"publisher","first-page":"e652","DOI":"10.1093\/cid\/ciaa1283","volume":"72","author":"J Ma","year":"2020","unstructured":"Ma, J. et al. Coronavirus Disease 2019 patients in earlier stages exhaled millions of Severe Acute Respiratory Syndrome Coronavirus 2 per hour. Clin. Infect. Dis. 72, e652\u2013e654. https:\/\/doi.org\/10.1093\/cid\/ciaa1283 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"7301_CR29","doi-asserted-by":"publisher","unstructured":"Zhou, L. et al. Breath-, air- and surface-borne SARS-CoV-2 in hospitals. J. Aerosol Sci. 152, 105693. https:\/\/doi.org\/10.1016\/j.jaerosci.2020.105693 (2021).","DOI":"10.1016\/j.jaerosci.2020.105693"},{"key":"7301_CR30","doi-asserted-by":"publisher","unstructured":"Feng, B. et al. Multi-route transmission potential of SARS-CoV-2 in healthcare facilities. J. Hazard. Mater. 402, 123771. https:\/\/doi.org\/10.1016\/j.jhazmat.2020.123771 (2021).","DOI":"10.1016\/j.jhazmat.2020.123771"},{"key":"7301_CR31","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1136\/thoraxjnl-2020-215705","volume":"76","author":"DJ Ryan","year":"2021","unstructured":"Ryan, D. J. et al. Use of exhaled breath condensate (EBC) in the diagnosis of SARS-CoV-2 (COVID-19). Thorax 76, 86\u201388. https:\/\/doi.org\/10.1136\/thoraxjnl-2020-215705 (2021).","journal-title":"Thorax"},{"key":"7301_CR32","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ijid.2021.07.012","volume":"110","author":"M Malik","year":"2021","unstructured":"Malik, M., Kunze, A.-C., Bahmer, T., Herget-Rosenthal, S. & Kunze, T. SARS-CoV-2: Viral loads of exhaled breath and oronasopharyngeal specimens in hospitalized patients with COVID-19. Int. J. Infect. Dis. 110, 105\u2013110. https:\/\/doi.org\/10.1016\/j.ijid.2021.07.012 (2021).","journal-title":"Int. J. Infect. Dis."},{"key":"7301_CR33","doi-asserted-by":"publisher","unstructured":"Li, Y. H., Fan, Y. Z., Jiang, L. & Wang, H. B. Aerosol and environmental surface monitoring for SARS-CoV-2 RNA in a designated hospital for severe COVID-19 patients. Epidemiol. Infect. 148, e154. https:\/\/doi.org\/10.1017\/S0950268820001570 (2020).","DOI":"10.1017\/S0950268820001570"},{"key":"7301_CR34","doi-asserted-by":"publisher","unstructured":"Samaddar, A. et al. Viral ribonucleic acid shedding and transmission potential of asymptomatic and paucisymptomatic coronavirus disease 2019 patients. Open Forum Infect. Dis. 8. https:\/\/doi.org\/10.1093\/ofid\/ofaa599 (2020).","DOI":"10.1093\/ofid\/ofaa599"},{"key":"7301_CR35","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1080\/23744235.2020.1810858","volume":"52","author":"M-C Kim","year":"2020","unstructured":"Kim, M.-C. et al. Effectiveness of surgical, KF94, and N95 respirator masks in blocking SARS-CoV-2: A controlled comparison in 7 patients. Infect. Dis. 52, 908\u2013912. https:\/\/doi.org\/10.1080\/23744235.2020.1810858 (2020).","journal-title":"Infect. Dis."},{"key":"7301_CR36","doi-asserted-by":"publisher","first-page":"13476","DOI":"10.1038\/s41598-021-92665-3","volume":"11","author":"A Smolinska","year":"2021","unstructured":"Smolinska, A. et al. The SARS-CoV-2 viral load in COVID-19 patients is lower on face mask filters than on nasopharyngeal swabs. Sci. Rep. 11, 13476. https:\/\/doi.org\/10.1038\/s41598-021-92665-3 (2021).","journal-title":"Sci. Rep."},{"key":"7301_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0249525","volume":"16","author":"K Sriraman","year":"2021","unstructured":"Sriraman, K. et al. Non-invasive adapted N-95 mask sampling captures variation in viral particles expelled by COVID-19 patients: Implications in understanding SARS-CoV-2 transmission. PLoS ONE 16, e0249525. https:\/\/doi.org\/10.1371\/journal.pone.0249525 (2021).","journal-title":"PLoS ONE"},{"key":"7301_CR38","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jinf.2021.03.018","volume":"82","author":"CM Williams","year":"2021","unstructured":"Williams, C. M. et al. Exhaled SARS-CoV-2 quantified by face-mask sampling in hospitalised patients with COVID-19. J. Infect. 82, 253\u2013259. https:\/\/doi.org\/10.1016\/j.jinf.2021.03.018 (2021).","journal-title":"J. Infect."},{"key":"7301_CR39","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1017\/ice.2020.58","volume":"41","author":"VCC Cheng","year":"2020","unstructured":"Cheng, V. C. C. et al. Escalating infection control response to the rapidly evolving epidemiology of the Coronavirus Disease 2019 (COVID-19) due to SARS-CoV-2 in Hong Kong. Infect. Control Hosp. Epidemiol. 41, 493\u2013498. https:\/\/doi.org\/10.1017\/ice.2020.58 (2020).","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"7301_CR40","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1017\/ice.2020.282","volume":"41","author":"VCC Cheng","year":"2020","unstructured":"Cheng, V. C. C. et al. Air and environmental sampling for SARS-CoV-2 around hospitalized patients with Coronavirus Disease 2019 (COVID-19). Infect. Control Hosp. Epidemiol. 41, 1258\u20131265. https:\/\/doi.org\/10.1017\/ice.2020.282 (2020).","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"7301_CR41","doi-asserted-by":"publisher","first-page":"141710","DOI":"10.1016\/j.scitotenv.2020.141710","volume":"753","author":"Z Ding","year":"2021","unstructured":"Ding, Z. et al. Toilets dominate environmental detection of Severe Acute Respiratory Syndrome Coronavirus 2 in a hospital. Sci. Total Environ. 753, 141710. https:\/\/doi.org\/10.1016\/j.scitotenv.2020.141710 (2021).","journal-title":"Sci. Total Environ."},{"key":"7301_CR42","doi-asserted-by":"publisher","unstructured":"Lin, Y.-C. et\u00a0al. Detection and quantification of infectious severe acute respiratory coronavirus-2 in diverse clinical and environmental samples from infected patients: Evidence to support respiratory droplet, and direct and indirect contact as significant modes of transmission. medRxiv. https:\/\/doi.org\/10.1101\/2021.07.08.21259744 (Pre-print).","DOI":"10.1101\/2021.07.08.21259744"},{"key":"7301_CR43","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41586-020-2196-x","volume":"581","author":"R W\u00f6lfel","year":"2020","unstructured":"W\u00f6lfel, R. et al. Virological assessment of hospitalized patients with COVID-2019. Nature 581, 465\u2013469. https:\/\/doi.org\/10.1038\/s41586-020-2196-x (2020).","journal-title":"Nature"},{"key":"7301_CR44","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41467-020-20568-4","volume":"12","author":"JJ van Kampen","year":"2021","unstructured":"van Kampen, J. J. et al. Duration and key determinants of infectious virus shedding in hospitalized patients with Coronavirus Disease-2019 (COVID-19). Nat. Commun. 12, 267. https:\/\/doi.org\/10.1038\/s41467-020-20568-4 (2021).","journal-title":"Nat. Commun."},{"key":"7301_CR45","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1093\/cid\/ciaa638","volume":"71","author":"J Bullard","year":"2020","unstructured":"Bullard, J. et al. Predicting infectious Severe Acute Respiratory Syndrome Coronavirus 2 from diagnostic samples. Clin. Infect. Dis. 71, 2663\u20132666. https:\/\/doi.org\/10.1093\/cid\/ciaa638 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"7301_CR46","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/S2213-2600(20)30323-4","volume":"8","author":"KP Fennelly","year":"2020","unstructured":"Fennelly, K. P. Particle sizes of infectious aerosols: Implications for infection control. Lancet Respir. Med. 8, 914\u2013924. https:\/\/doi.org\/10.1016\/S2213-2600(20)30323-4 (2020).","journal-title":"Lancet Respir. Med."},{"key":"7301_CR47","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1056\/NEJMc2031670","volume":"383","author":"T Aydillo","year":"2020","unstructured":"Aydillo, T. et al. Shedding of Viable SARS-CoV-2 after immunosuppressive therapy for cancer. N. Engl. J. Med. 383, 2586\u20132588. https:\/\/doi.org\/10.1056\/NEJMc2031670 (2020).","journal-title":"N. Engl. J. Med."},{"key":"7301_CR48","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/infdis\/jiaa666","volume":"223","author":"JH Baang","year":"2020","unstructured":"Baang, J. H. et al. Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 replication in an immunocompromised patient. J. Infect. Dis. 223, 23\u201327. https:\/\/doi.org\/10.1093\/infdis\/jiaa666 (2020).","journal-title":"J. Infect. Dis."},{"key":"7301_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ofid\/ofab217","volume":"8","author":"C Sepulcri","year":"2021","unstructured":"Sepulcri, C. et al. The longest persistence of viable SARS-CoV-2 with recurrence of viremia and relapsing symptomatic COVID-19 in an immunocompromised patient - a case study. Open Forum Infect. Dis. 8, 1\u20137. https:\/\/doi.org\/10.1093\/ofid\/ofab217 (2021).","journal-title":"Open Forum Infect. Dis."},{"key":"7301_CR50","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1093\/infdis\/jiab075","volume":"223","author":"H Tarhini","year":"2021","unstructured":"Tarhini, H. et al. Long-term Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infectiousness among three immunocompromised patients: From prolonged viral shedding to SARS-CoV-2 superinfection. J. Infect. Dis. 223, 1522\u20131527. https:\/\/doi.org\/10.1093\/infdis\/jiab075 (2021).","journal-title":"J. Infect. Dis."},{"key":"7301_CR51","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1080\/02786826.2021.1910137","volume":"55","author":"S Ratnesar-Shumate","year":"2021","unstructured":"Ratnesar-Shumate, S. et al. Comparison of the performance of aerosol sampling devices for measuring infectious SARS-CoV-2 aerosols. Aerosol Sci. Technol. 55, 975\u2013986. https:\/\/doi.org\/10.1080\/02786826.2021.1910137 (2021).","journal-title":"Aerosol Sci. Technol."},{"key":"7301_CR52","doi-asserted-by":"publisher","unstructured":"Oswin, H. P. et al. The dynamics of SARS-CoV-2 infectivity with changes in aerosol microenvironment. medRxiv. https:\/\/doi.org\/10.1101\/2022.01.08.22268944 (Pre-print).","DOI":"10.1101\/2022.01.08.22268944"},{"key":"7301_CR53","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1080\/02786826.2020.1829536","volume":"55","author":"P Dabisch","year":"2021","unstructured":"Dabisch, P. et al. The influence of temperature, humidity, and simulated sunlight on the infectivity of SARS-CoV-2 in aerosols. Aerosol Sci. Technol. 55, 142\u2013153. https:\/\/doi.org\/10.1080\/02786826.2020.1829536 (2021).","journal-title":"Aerosol Sci. Technol."},{"key":"7301_CR54","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1056\/NEJMc2004973","volume":"382","author":"N van Doremalen","year":"2020","unstructured":"van Doremalen, N. et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N. Engl. J. Med. 382, 1564\u20131567. https:\/\/doi.org\/10.1056\/NEJMc2004973 (2020).","journal-title":"N. Engl. J. Med."},{"key":"7301_CR55","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/JOM.0000000000000448","volume":"57","author":"RM Jones","year":"2015","unstructured":"Jones, R. M. & Brosseau, L. M. Aerosol transmission of infectious disease. J. Occup. Environ. Med. 57, 501\u2013508. https:\/\/doi.org\/10.1097\/JOM.0000000000000448 (2015).","journal-title":"J. Occup. Environ. Med."},{"key":"7301_CR56","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/02786828708959166","volume":"7","author":"DH Pui","year":"1987","unstructured":"Pui, D. H., Romay-Novas, F. & Liu, B. Y. Experimental study of particle deposition in bends of circular cross section. Aerosol Sci. Technol. 7, 301\u2013315. https:\/\/doi.org\/10.1080\/02786828708959166 (1987).","journal-title":"Aerosol Sci. Technol."},{"key":"7301_CR57","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/15459624.2014.973113","volume":"12","author":"WG Lindsley","year":"2015","unstructured":"Lindsley, W. G. et al. Viable Influenza A virus in airborne particles from human coughs. J. Occup. Environ. Hyg. 12, 107\u2013113. https:\/\/doi.org\/10.1080\/15459624.2014.973113 (2015).","journal-title":"J. Occup. Environ. Hyg."},{"key":"7301_CR58","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1080\/02786829808965536","volume":"28","author":"K Willeke","year":"1998","unstructured":"Willeke, K., Lin, X. & Grinshpun, S. A. Improved aerosol collection by combined impaction and centrifugal motion. Aerosol Sci. Technol. 28, 439\u2013456. https:\/\/doi.org\/10.1080\/02786829808965536 (1998).","journal-title":"Aerosol Sci. Technol."},{"key":"7301_CR59","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1111\/j.1365-2672.2005.02720.x","volume":"99","author":"C Hogan Jr","year":"2005","unstructured":"Hogan, C. Jr. et al. Sampling methodologies and dosage assessment techniques for submicrometre and ultrafine virus aerosol particles. J. Appl. Microbiol. 99, 1422\u20131434. https:\/\/doi.org\/10.1111\/j.1365-2672.2005.02720.x (2005).","journal-title":"J. Appl. Microbiol."},{"key":"7301_CR60","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/jam.13051","volume":"120","author":"M Pan","year":"2016","unstructured":"Pan, M. et al. Efficient collection of viable virus aerosol through laminar-flow, water-based condensational particle growth. J. Appl. Microbiol. 120, 805\u2013815. https:\/\/doi.org\/10.1111\/jam.13051 (2016).","journal-title":"J. Appl. Microbiol."},{"key":"7301_CR61","unstructured":"Fairbanks, G. Pitch. In Voice and Articulation Drillbook, chap.\u00a011, 2 ed, 122\u2013134 (Harper & Row, 1960)."},{"key":"7301_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0227699","volume":"15","author":"S Asadi","year":"2020","unstructured":"Asadi, S. et al. Effect of voicing and articulation manner on aerosol particle emission during human speech. PLoS ONE 15, 1\u201315. https:\/\/doi.org\/10.1371\/journal.pone.0227699 (2020).","journal-title":"PLoS ONE"},{"key":"7301_CR63","unstructured":"World Health Organization. Laboratory testing for Coronavirus Disease (COVID-19) in suspected human cases. Interim guidance, 2 March 2020. https:\/\/apps.who.int\/iris\/handle\/10665\/331329 (2020). (accessed June 2021)."},{"key":"7301_CR64","unstructured":"Centers for Disease Control and Prevention (CDC). CDC 2019-novel coronavirus (2019-nCoV) real-time RT-PCR diagnostic panel, CDC-006-00019. https:\/\/www.fda.gov\/media\/134922\/download (2021). (accessed June 2021)."},{"key":"7301_CR65","doi-asserted-by":"publisher","unstructured":"Warnke, P., Warning, L. & Podbielski, A. Some are more equal - a comparative study on swab uptake and release of bacterial suspensions. PLOS One 9, e102215. https:\/\/doi.org\/10.1371\/journal.pone.0102215 (2014).","DOI":"10.1371\/journal.pone.0102215"},{"key":"7301_CR66","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1126\/science.abg6296","volume":"372","author":"Y Cheng","year":"2021","unstructured":"Cheng, Y. et al. Face masks effectively limit the probability of SARS-CoV-2 transmission. Science 372, 1439\u20131443. https:\/\/doi.org\/10.1126\/science.abg6296 (2021).","journal-title":"Science"},{"key":"7301_CR67","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/s41591-020-0843-2","volume":"26","author":"NHL Leung","year":"2020","unstructured":"Leung, N. H. L. et al. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat. Med. 26, 676\u2013680. https:\/\/doi.org\/10.1038\/s41591-020-0843-2 (2020).","journal-title":"Nat. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-07301-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-07301-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-07301-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T18:33:46Z","timestamp":1669314826000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-07301-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,3]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["7301"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-07301-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,3]]},"assertion":[{"value":"6 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.H.E. holds research contracts from Tonix Pharmaceuticals concerning the construction of poxvirus-vectored COVID-19 vaccines. He also holds a contract from Singletto Inc. concerning methods for inactivating SARS-CoV-2. J.M.C. holds grants from the Canadian Institutes for Health Research on acute and primary care preparedness for COVID 19 in Alberta, Canada and was the primary local Investigator for a Staphylococcus aureus vaccine study funded by Pfizer for which all funding was provided only to the University of Calgary. He is a co-investigator on a WHO funded study using integrated human factors and ethnography approaches to identify and scale innovative IPC guidance implementation supports in primary care with a focus on low resource settings and using drone aerial systems to deliver medical supplies and PPE to remote First Nations communities during the COVID 19 pandemic. He also received support from the Centers for Disease Control and Prevention (CDC) to attend an Infection Control Think Tank Meeting. He is a member and Chair of the WHO Infection Prevention and Control Research and Development Expert Group for COVID 19 and a member of the WHO Health Emergencies Programme (WHE) Ad hoc COVID 19 IPC Guidance Development Group, both of which provide multidisciplinary advice to the WHO, for which no funding is received and from which no funding recommendations are made for any WHO contracts or grants. He is also a member of the Cochrane Acute Respiratory Infections Group. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3484"}}